Latest Insights in Publications
Study shows Lodestar DX accurately identifies uropathogens in mixed growth cultures
A new abstract published in JAC-Antimicrobial Resistance demonstrates that the Lodestar DX UTI testing system can ‘accurately identify the common…
Two abstracts published by JAC-AMR
Two abstracts written by Llusern researchers that discuss the need for better point-of-care diagnostics for UTIs have been published by…
Start a conversation with Llusern
Llusern is developing treatment-directing diagnostics for high-volume healthcare challenges, starting with rapid molecular UTI testing. To learn more about the company, the product and the opportunity ahead, speak to the Llusern team.
